PC
ELV icon

Polar Capital’s Elevance Health ELV Stock Holding History

Polar Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$27.5M Sell
102,234
-3,876
-4% -$1.04M 0.2% 109
2020
Q2 		$27.9M Sell
106,110
-100,353
-49% -$26.8M 0.24% 108
2020
Q1 		$46.9M Buy
206,463
+13,010
+7% +$3.55M 0.5% 61
2019
Q4 		$58.4M Sell
193,453
-86,347
-31% -$23.8M 0.51% 53
2019
Q3 		$67.2M Sell
279,800
-37,980
-12% -$10.4M 0.6% 42
2019
Q2 		$89.7M Buy
317,780
+45,791
+17% +$12.5M 0.79% 28
2019
Q1 		$78.1M Sell
271,989
-27,847
-9% -$8.05M 0.72% 33
2018
Q4 		$78.7M Sell
299,836
-8,560
-3% -$2.35M 0.84% 28
2018
Q3 		$84.5M Sell
308,396
-89,512
-22% -$23.2M 0.72% 37
2018
Q2 		$94.7K Sell
397,908
-191,188
-32% -$44.3M 0.57% 25
2018
Q1 		$129M Sell
589,096
-124,372
-17% -$29.2M 1.31% 12
2017
Q4 		$161M Sell
713,468
-8,397
-1% -$1.79M 1.66% 9
2017
Q3 		$137M Buy
721,865
+30,000
+4% +$5.71M 1.54% 8
2017
Q2 		$130M Sell
691,865
-11,891
-2% -$2.14M 1.75% 7
2017
Q1 		$116M Sell
703,756
-63,200
-8% -$10.1M 1.74% 7
2016
Q4 		$110M Buy
766,956
+258,417
+51% +$34.6M 1.76% 9
2016
Q3 		$63.7M Buy
508,539
+23,291
+5% +$3.01M 1.1% 24
2016
Q2 		$63.7M Buy
485,248
+25,931
+6% +$3.55M 1.2% 20
2016
Q1 		$63.8M Sell
459,317
-1,995
-0.4% -$267K 1.2% 19
2015
Q4 		$64.3M Buy
461,312
+131,128
+40% +$18.1M 1.16% 20
2015
Q3 		$46.2M Sell
330,184
-8,442
-2% -$1.27M 0.94% 25
2015
Q2 		$55.6M Sell
338,626
-61,910
-15% -$9.89M 1.07% 18
2015
Q1 		$61.8M Sell
400,536
-37,745
-9% -$5.37M 1.17% 14
2014
Q4 		$55.1M Buy
438,281
+49,041
+13% +$6.06M 1.07% 28
2014
Q3 		$46.6M Buy
389,240
+12,483
+3% +$1.43M 0.98% 26
2014
Q2 		$40.5M Buy
376,757
+1,903
+0.5% +$196K 0.86% 25
2014
Q1 		$37.3M Buy
374,854
+88,745
+31% +$8.03M 0.85% 28
2013
Q4 		$26.4M Buy
286,109
+75,803
+36% +$6.74M 0.63% 48
2013
Q3 		$17.6K Buy
210,306
+46,348
+28% +$3.97M 0.47% 66
2013
Q2 		$13.4M Buy
+163,958
New +$12.3M 0.47% 71

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polar Capital's ELV Position: Q3 2020 in Review

Polar Capital reduced its Elevance Health (ELV) stake by 3.7% in Q3 2020, selling an estimated $1.04M and leaving 102,234 shares worth $27.5M. The position accounts for 0.2% of the portfolio, ranked #109.

Polar Capital first reported a position in ELV in Q2 2013 and has held it in 30 quarters since. The position peaked at $161M in Q4 2017. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Polar Capital held 102,234 shares of Elevance Health worth $27.5M as of Q3 2020.
  • Polar Capital sold 3,876 Elevance Health shares in Q3 2020, an estimated $1.04M.
  • Elevance Health made up 0.2% of Polar Capital's portfolio in Q3 2020, its #109 holding.
  • Polar Capital first reported a position in Elevance Health in Q2 2013 and has held it in 30 quarters since.
  • Polar Capital's Elevance Health position peaked at $161M in Q4 2017.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.